Viemed Healthcare, Inc. (VMD)

Viemed Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	13.98	11.41	10.24	6.22	9.13	31.53
Depreciation & Amortization	27.41	25.37	21.86	15.63	11.31	9.58
Stock-Based Compensation	8.35	6.29	5.85	5.2	5.15	4.88
Other Adjustments	-0.02	-4.33	-0.52	0.82	10.47	-0.68
Change in Receivables	1.47	-6.07	-1.06	-2.56	-7.35	-9.96
Changes in Inventories	-0.17	0.57	-0.47	0.3	-0.21	-2.3
Changes in Accounts Payable	0.38	0.36	-0.86	-0.32	0.13	0.21
Changes in Accrued Expenses	2.02	2.86	4.96	2.55	-4.02	2.31
Changes in Income Taxes Payable	-3.99	1.73	2.18	1.87	-2.23	0.25
Changes in Unearned Revenue	0.5	0.36	0.85	0.87	0.34	0.09
Changes in Other Operating Activities	-0.42	0.54	2.18	-2.84	-0.23	-0.81
Operating Cash Flow	48.46	39.09	45.21	27.75	22.49	35.11
Operating Cash Flow Growth	29.63%	-13.54%	62.94%	23.36%	-35.93%	83.95%
Capital Expenditures	-43.08	-37.77	-26.09	-22.9	-19.74	-13.04
Sale of Property, Plant & Equipment	17.91	10.32	2.59	1.06	0.6	5.26
Purchases of Investments	-	-1	-0.02	-2.14	-0.6	-0.63
Proceeds from Sale of Investments	-	0.75	-	-	-	-
Payments for Business Acquisitions	-26.33	-3	-28.59	-	-	-
Investing Cash Flow	-51.75	-30.7	-52.11	-23.98	-19.75	-8.42
Short-Term Debt Issued	13	3	8	-	-	-
Short-Term Debt Repaid	-	-5	-7.01	-	-	-
Net Short-Term Debt Issued (Repaid)	13	-2	1	-	-	-
Long-Term Debt Issued	-	-	5	-	-	-
Long-Term Debt Repaid	-0.6	-1.07	-3.72	-5.8	-1.84	-1.75
Net Long-Term Debt Issued (Repaid)	-0.6	-1.07	1.28	-5.8	-1.84	-1.75
Issuance of Common Stock	2.04	1.02	1.3	0.28	0.11	1.88
Repurchase of Common Stock	-14.13	-1.07	-0.59	-9.71	-1.43	-
Net Common Stock Issued (Repurchased)	-12.09	-0.05	0.71	-9.43	-1.32	1.88
Other Financing Activities	-0.32	-0.57	-0.16	-0.04	-2.16	-9.2
Financing Cash Flow	3.07	-3.69	2.83	-15.27	-5.32	-9.07
Net Cash Flow	-0.22	4.7	-4.08	-11.49	-2.57	17.63
Free Cash Flow	5.39	1.32	19.12	4.85	2.75	22.07
Free Cash Flow Growth	308.57%	-93.11%	294.21%	76.30%	-87.53%	286.99%
FCF Margin	2.11%	0.59%	10.45%	3.49%	2.35%	16.80%
Free Cash Flow Per Share	0.13	0.03	0.47	0.12	0.07	0.54
Levered Free Cash Flow	8.65	2.22	17.12	-4.41	-7.36	26.08
Unlevered Free Cash Flow	-2.7	6.65	14.8	0.88	-6.19	28.32

Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q